CY1114081T1 - Σπειροοξετανικα νουκλεοσιδια ουρακιλης ονες - Google Patents
Σπειροοξετανικα νουκλεοσιδια ουρακιλης ονεςInfo
- Publication number
- CY1114081T1 CY1114081T1 CY20131100408T CY131100408T CY1114081T1 CY 1114081 T1 CY1114081 T1 CY 1114081T1 CY 20131100408 T CY20131100408 T CY 20131100408T CY 131100408 T CY131100408 T CY 131100408T CY 1114081 T1 CY1114081 T1 CY 1114081T1
- Authority
- CY
- Cyprus
- Prior art keywords
- phenyl
- optionally substituted
- uracial
- nuclears
- spires
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Ενώσεις του τύπου (I) που περιλαμβάνουν οποιαδήποτε πιθανά στερεοϊσομερή αυτών, όπου: το R4 είναι ένας μονοφωσφορικός, διφωσφορικός ή τριφωσφορικός εστέρας· ή το R4 είναι ο τύπος (II) ή ο τύπος (III), το R7 είναι προαιρετικά υποκατεστημένο φαινύλιο, προαιρετικά υποκατεστημένο ναφθύλιο, ή προαιρετικά υποκατεστημένο ινδολύλιο· τα R8 και R8 είναι υδρογόνο, C1-C6αλκύλιο, βενζύλιο, ή φαινύλιο· ή τα R8 και R8’ σχηματίζουν C3-C7κυκλοαλκύλιο· το R9 είναι C1-C10αλκύλιο, C3-C7κυκλοαλκύλιο, φαινύλιο ή φαινυλο-C1-C6αλκύλιο, όπου το τμήμα φαινυλίου στο φαινύλιο ή στο φαινυλο-C1-C6αλκύλιο είναι προαιρετικά υποκατεστημένο· ή ένα φαρμακευτικά αποδεκτό άλας ή διάλυμα αυτών φαρμακευτικά σκευάσματα και χρήση των ενώσεων I ως αναστολέων του HCV.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09160215 | 2009-05-14 | ||
EP10718207A EP2430035B1 (en) | 2009-05-14 | 2010-05-11 | Uracyl spirooxetane nucleosides |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1114081T1 true CY1114081T1 (el) | 2016-07-27 |
Family
ID=40823307
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20131100408T CY1114081T1 (el) | 2009-05-14 | 2013-05-22 | Σπειροοξετανικα νουκλεοσιδια ουρακιλης ονες |
CY20141100491T CY1115383T1 (el) | 2009-05-14 | 2014-07-01 | Σπειροοξετανικα νουκλεοσιδια ουρακιλης |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100491T CY1115383T1 (el) | 2009-05-14 | 2014-07-01 | Σπειροοξετανικα νουκλεοσιδια ουρακιλης |
Country Status (39)
Country | Link |
---|---|
US (2) | US8481510B2 (el) |
EP (2) | EP2430035B1 (el) |
JP (2) | JP5778135B2 (el) |
KR (1) | KR101806837B1 (el) |
CN (1) | CN102439024B (el) |
AP (1) | AP2783A (el) |
AR (1) | AR076579A1 (el) |
AU (1) | AU2010247439B2 (el) |
BR (1) | BRPI1010579A2 (el) |
CA (1) | CA2760329C (el) |
CL (1) | CL2011002859A1 (el) |
CO (1) | CO6440533A2 (el) |
CR (1) | CR20120297A (el) |
CY (2) | CY1114081T1 (el) |
DK (2) | DK2511282T3 (el) |
EA (1) | EA022084B1 (el) |
EC (1) | ECSP11011461A (el) |
ES (2) | ES2477598T3 (el) |
HK (1) | HK1166326A1 (el) |
HN (1) | HN2011003014A (el) |
HR (2) | HRP20130554T1 (el) |
IL (1) | IL215955A (el) |
JO (1) | JO3027B1 (el) |
ME (1) | ME01478B (el) |
MX (1) | MX2011012027A (el) |
MY (1) | MY157018A (el) |
NI (1) | NI201100197A (el) |
NZ (1) | NZ596073A (el) |
PL (2) | PL2430035T3 (el) |
PT (2) | PT2511282E (el) |
RS (1) | RS52822B (el) |
SG (1) | SG175981A1 (el) |
SI (2) | SI2430035T1 (el) |
SM (2) | SMT201300078B (el) |
TW (1) | TWI461432B (el) |
UA (1) | UA105790C2 (el) |
UY (1) | UY32642A (el) |
WO (1) | WO2010130726A1 (el) |
ZA (1) | ZA201108309B (el) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
KR20110104074A (ko) | 2008-12-23 | 2011-09-21 | 파마셋 인코포레이티드 | 퓨린 뉴클레오시드의 합성 |
JO3027B1 (ar) | 2009-05-14 | 2016-09-05 | Janssen Products Lp | نيوكليوسيدات يوراسيل سبيرواوكسيتان |
WO2012062869A1 (en) * | 2010-11-10 | 2012-05-18 | Janssen Products, Lp | Uracyl spirooxetane nucleoside phosphoramidates |
PT2638054E (pt) | 2010-11-10 | 2015-03-02 | Medivir Ab | Fosforamidatos de nucleósidos de uracilo espirooxetano |
WO2012075140A1 (en) * | 2010-11-30 | 2012-06-07 | Pharmasset, Inc. | Compounds |
AU2015252113B2 (en) * | 2010-11-30 | 2017-05-04 | Gilead Pharmasset Llc | Compounds |
US8877733B2 (en) * | 2011-04-13 | 2014-11-04 | Gilead Sciences, Inc. | 1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment |
EP2794630A4 (en) * | 2011-12-22 | 2015-04-01 | Alios Biopharma Inc | SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE |
AR091156A1 (es) | 2012-05-25 | 2015-01-14 | Jansen R & D Ireland | Nucleosidos de espirooxetano de uracilo |
AU2014225052B2 (en) * | 2013-03-08 | 2016-11-10 | Nanjing Sanhome Pharmaceutical Co., Ltd. | Novel nucleoside phosphoramidate compound and use thereof |
BR112015025766A2 (pt) | 2013-04-12 | 2017-10-17 | Achillion Pharmaceuticals Inc | derivado de nucleosídeo altamente ativo para o tratamento de hcv |
CN104231023B (zh) * | 2013-06-06 | 2019-02-05 | 南京汇诚制药有限公司 | 三环稠杂环类核苷氨基磷酸酯化合物、其制备方法及应用 |
US20170165287A1 (en) * | 2013-11-28 | 2017-06-15 | Janssen Sciences Ireland Uc | Crystal form of a nucleoside inhibitor of hcv |
KR102363946B1 (ko) | 2015-03-06 | 2022-02-17 | 아테아 파마슈티컬즈, 인크. | HCV 치료를 위한 β-D-2'-데옥시-2'-α-플루오로-2'-β-C-치환된-2-변형된-N6-치환된 퓨린 뉴클레오티드 |
WO2018013937A1 (en) | 2016-07-14 | 2018-01-18 | Atea Pharmaceuticals, Inc. | Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection |
EP4088725A1 (en) | 2016-09-07 | 2022-11-16 | ATEA Pharmaceuticals, Inc. | 2'-substituted-n6-substituted purine nucleotides for the treatment of a virus from the picornaviridae family |
UA127407C2 (uk) | 2017-02-01 | 2023-08-16 | Атеа Фармасеутікалс, Інк. | Гемісульфатна сіль нуклеотиду для лікування спричиненого вірусом гепатиту с захворювання |
JP2021521118A (ja) | 2018-04-10 | 2021-08-26 | アテア ファーマシューティカルズ, インコーポレイテッド | 肝硬変を伴うhcv感染患者の治療 |
US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
EP4135716A1 (en) * | 2020-04-14 | 2023-02-22 | Janssen Pharmaceuticals, Inc. | Spirocyclic nucleoside analogues for the treatment of hepatitis e |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0400726A3 (en) * | 2001-01-22 | 2007-05-29 | Merck & Co Inc | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
EP1773355B1 (en) * | 2004-06-24 | 2014-06-25 | Merck Sharp & Dohme Corp. | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
WO2007020193A2 (en) * | 2005-08-15 | 2007-02-22 | F. Hoffmann-La Roche Ag | Antiviral phosphoramidates of 4 ' -substituted pronucleotides |
US7879815B2 (en) * | 2006-02-14 | 2011-02-01 | Merck Sharp & Dohme Corp. | Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection |
PA8852101A1 (es) * | 2008-12-08 | 2010-07-27 | Medivir Ab | Nucleótidos uracil ciclopropílicos |
JO3027B1 (ar) | 2009-05-14 | 2016-09-05 | Janssen Products Lp | نيوكليوسيدات يوراسيل سبيرواوكسيتان |
-
2010
- 2010-05-04 JO JOP/2010/0138A patent/JO3027B1/ar active
- 2010-05-11 PL PL10718207T patent/PL2430035T3/pl unknown
- 2010-05-11 EP EP10718207A patent/EP2430035B1/en active Active
- 2010-05-11 DK DK12176402.1T patent/DK2511282T3/da active
- 2010-05-11 CA CA2760329A patent/CA2760329C/en active Active
- 2010-05-11 US US13/319,735 patent/US8481510B2/en active Active
- 2010-05-11 KR KR1020117029826A patent/KR101806837B1/ko active IP Right Grant
- 2010-05-11 JP JP2012510269A patent/JP5778135B2/ja not_active Expired - Fee Related
- 2010-05-11 EA EA201171406A patent/EA022084B1/ru not_active IP Right Cessation
- 2010-05-11 ME MEP-2013-47A patent/ME01478B/me unknown
- 2010-05-11 SI SI201030246T patent/SI2430035T1/sl unknown
- 2010-05-11 ES ES12176402.1T patent/ES2477598T3/es active Active
- 2010-05-11 PT PT121764021T patent/PT2511282E/pt unknown
- 2010-05-11 DK DK10718207.3T patent/DK2430035T3/da active
- 2010-05-11 AP AP2011005958A patent/AP2783A/xx active
- 2010-05-11 BR BRPI1010579A patent/BRPI1010579A2/pt active Search and Examination
- 2010-05-11 NZ NZ596073A patent/NZ596073A/xx not_active IP Right Cessation
- 2010-05-11 MX MX2011012027A patent/MX2011012027A/es active IP Right Grant
- 2010-05-11 MY MYPI2011005445A patent/MY157018A/en unknown
- 2010-05-11 SI SI201030667T patent/SI2511282T1/sl unknown
- 2010-05-11 PT PT107182073T patent/PT2430035E/pt unknown
- 2010-05-11 EP EP12176402.1A patent/EP2511282B1/en active Active
- 2010-05-11 PL PL12176402T patent/PL2511282T3/pl unknown
- 2010-05-11 ES ES10718207T patent/ES2411086T3/es active Active
- 2010-05-11 RS RS20130213A patent/RS52822B/en unknown
- 2010-05-11 SG SG2011082757A patent/SG175981A1/en unknown
- 2010-05-11 AU AU2010247439A patent/AU2010247439B2/en not_active Ceased
- 2010-05-11 CN CN201080021188.8A patent/CN102439024B/zh active Active
- 2010-05-11 WO PCT/EP2010/056438 patent/WO2010130726A1/en active Application Filing
- 2010-05-12 TW TW099115051A patent/TWI461432B/zh not_active IP Right Cessation
- 2010-05-13 AR ARP100101670A patent/AR076579A1/es unknown
- 2010-05-14 UY UY0001032642A patent/UY32642A/es unknown
- 2010-11-05 UA UAA201112920A patent/UA105790C2/uk unknown
-
2011
- 2011-10-26 IL IL215955A patent/IL215955A/en not_active IP Right Cessation
- 2011-10-27 CO CO11145588A patent/CO6440533A2/es not_active Application Discontinuation
- 2011-11-11 ZA ZA2011/08309A patent/ZA201108309B/en unknown
- 2011-11-11 NI NI201100197A patent/NI201100197A/es unknown
- 2011-11-14 EC EC2011011461A patent/ECSP11011461A/es unknown
- 2011-11-14 HN HN2011003014A patent/HN2011003014A/es unknown
- 2011-11-14 CL CL2011002859A patent/CL2011002859A1/es unknown
-
2012
- 2012-05-30 CR CR20120297A patent/CR20120297A/es unknown
- 2012-07-18 HK HK12107046.5A patent/HK1166326A1/xx unknown
-
2013
- 2013-03-15 US US13/836,465 patent/US8933052B2/en active Active
- 2013-05-22 CY CY20131100408T patent/CY1114081T1/el unknown
- 2013-06-18 HR HRP20130554AT patent/HRP20130554T1/hr unknown
- 2013-07-04 SM SM201300078T patent/SMT201300078B/xx unknown
-
2014
- 2014-06-26 HR HRP20140605AT patent/HRP20140605T1/hr unknown
- 2014-06-30 SM SM201400085T patent/SMT201400085B/xx unknown
- 2014-07-01 CY CY20141100491T patent/CY1115383T1/el unknown
-
2015
- 2015-07-06 JP JP2015135001A patent/JP2015180692A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1114081T1 (el) | Σπειροοξετανικα νουκλεοσιδια ουρακιλης ονες | |
CY1124206T1 (el) | Αναστολεις πυριδοπυριμδινονης cdk2/4/6 | |
CY1124117T1 (el) | Ετεροκυκλικες αλκυνυλοβενζολικες ενωσεις και ιατρικες συνθεσεις και χρησεις αυτων | |
CY1119015T1 (el) | 4'-αζιδο-3'φθορο υποκατεστημενα νουκλεοζιδιου παραγωγα ως αναστολεις αντιγραφης hcv rna | |
CY1119056T1 (el) | Παραγωγα 2',4',-διφθορο-2'-μεθυλ υποκατεστημενου νουκλεοσιδιου ως αναστολεις αντιγραφης hcv rna | |
CY1118879T1 (el) | Ενωσεις τριαζινης ως αναστολεις κινασης ρ13 και mtor | |
EA201170118A1 (ru) | Циклопропильные ингибиторы полимеразы | |
EA201170780A1 (ru) | Урацильные циклопропилнуклеотиды | |
CY1117481T1 (el) | Φαρμακευτικη συνθεση που περιεχει παραγωγο κινολινης | |
CY1118915T1 (el) | Αντιβακτηριακα αναλογα αμινογλυκοσιδης | |
HN2010000653A (es) | Derivados de pirrolo [2,3-d] pirimidina como inhibidores de proteinas quinasas b | |
AR077765A1 (es) | Inhibidores de los virus flaviviridae | |
EA201390163A1 (ru) | Гетеробициклические производные в качетстве ингибиторов hcv | |
EA201200049A1 (ru) | 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17 | |
NO20090835L (no) | Nye HIV-reverstranskriptaseinhibitorer | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
CY1113395T1 (el) | Σταθερη φαρμακευτικη συνθεση που περιεχει πυριμιδινη-σουλφαμιδη | |
EA201170153A1 (ru) | Микроциклические производные индола, пригодные в качестве ингибиторов вируса гепатита с | |
EA201070424A1 (ru) | Хиназолиндионовые производные, их получение и их применения в терапии | |
CU20090048A7 (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CY1114140T1 (el) | Ενωσεις 4-πυριδινονης και η χρηση αυτων για τον καρκινο | |
CO6382176A2 (es) | Derivados de urea heterociclicos y metodos de uso de los mismos-332 | |
UY32316A (es) | Derivados de piperidina utiles en el tratamiento de infecciones bacterianas | |
RS54736B1 (sr) | Postupak za sintezu derivata 3,6-dihidro-1,3,5-triazina | |
RS53032B (en) | DIHIDRO-OXAZOLOBENZODIAZEPINONE DERIVATIVES, PROCEDURES FOR THEIR PRODUCTION AND THE PHARMACEUTICAL MIXTURES CONTAINING THESE COMPOUNDS |